Preferred Label : orgovyx;
Origin ID : M000750566;
Related record
https://www.has-sante.fr/jcms/p_3434157/fr/orgovyx-relugolix-cancer-de-la-prostate-avance-hormonodependant
2023
false
false
false
France
orgovyx
neoplasms, hormone-dependent
treatment outcome
insurance, health, reimbursement
advanced hormone-dependent prostate cancer
adult
Product containing precisely relugolix 120 milligram/1 each conventional release oral
tablet (clinical drug)
administration, oral
relugolix
androgen antagonists
evaluation of the transparency committee
relugolix
prostatic neoplasms
---
